FWWNX | MASGX | FWWNX / MASGX | |
Total Expense Ratio | 0.63 | 1.34 | 47% |
Annual Report Gross Expense Ratio | 0.63 | 1.37 | 46% |
Fund Existence | 5 years | 10 years | - |
Gain YTD | 23.509 | 18.776 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 74.1B | 217M | 34,147% |
Annual Yield % from dividends | 1.02 | 2.32 | 44% |
Returns for 1 year | 17.08 | 13.53 | 126% |
Returns for 3 years | 51.81 | 16.91 | 306% |
Returns for 5 years | N/A | 14.91 | - |
Returns for 10 years | N/A | 71.71 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VLAAX | 41.28 | 0.08 | +0.19% |
Value Line Asset Allocation Investor | |||
JDEAX | 48.00 | N/A | N/A |
JPMorgan US Research Enhanced Equity A | |||
MBCYX | 26.20 | N/A | N/A |
MassMutual Blue Chip Growth Svc | |||
IGFSX | 11.25 | N/A | N/A |
VY® Morgan Stanley Global Franchise S2 | |||
RUSRX | 10.51 | N/A | N/A |
Lazard US Systematic Small Cap Eq R6 |